Articles published by Acuitive Technologies

Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration

November 20, 2025

From Acuitive Technologies

Via GlobeNewswire

Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer

January 27, 2025

From Acuitive Technologies

Via GlobeNewswire

Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures

November 12, 2024

From Acuitive Technologies

Via GlobeNewswire

Acuitive Technologies Receives FDA 510(k) Clearance for CITRELOCK DUO a New Sports Medicine Fixation Device for Biceps Tenodesis and Tendon Transfer Procedures

September 27, 2023

From Acuitive Technologies

Via GlobeNewswire

Acuitive Technologies Launches New Tendon Fixation Device for Sports Medicine

June 29, 2023

From Acuitive Technologies

Via GlobeNewswire

Two Industry Veterans Join Acuitive Technologies, Inc. Board of Directors as Independent Members

March 13, 2023

From Acuitive Technologies

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.